Journal of Clinical Pediatrics >
Early-onset epileptic encephalopathy type 27 caused by missense variation of GRIN2B gene: a case report
Received date: 2021-04-12
Online published: 2022-04-07
Early-onset epileptic encephalopathy (EOEE) is a kind of epileptic syndrome that appears in neonatal period or early infancy. It has genetic heterogeneity and is characterized by early onset, refractory, multiple seizure types and overall developmental retardation or regression. The clinical data of a child with early-onset epileptic encephalopathy type 27 caused by GRIN2B gene variation were reviewed. The patient was a 12-month-old girl who developed the disease on the second day after birth, presenting with refractory epilepsy, psychomotor retardation, and hypotonia. Cranial magnetic resonance imaging showed bilateral frontal subarachnoid space widening. Long range video electroencephalogram showed multifocal sharp waves and spike waves in each waking and sleeping period, as well as abnormal brain discharges corresponding to the clinical onset, suggesting sharp waves and spike slow waves in the right frontal lobe and central region during sleeping period. Whole exon gene sequencing revealed a novel heterozygous missense variation of c.2635G>A (p. Glu879Lys) (NM_000834) in GRIN2B gene of the proband. The parental and elder brother genotypes were wild-type and the child was considered as early-onset epileptic encephalopathy type 27. No literature was reported on this locus variant. According to the 2015 guidelines of the American College of Medical Genetics and Genomics, it was considered likely pathogenic. Topiramate, ocasepine and rehabilitation function training were used for treatment. During the follow-up, the development of the patient was found to be behind that of normal children of the same age, and there was no epileptic seizure and no abnormal discharge in electroencephalogram. The GRIN2B gene missense variant of (NM_000834):c.2635G>A (p.Glu879Lys) is a possible cause of the proband.
Daoqi MEI , Shiyue MEI , Xiaona WANG , Yuan WANG , Guohong CHEN , Zhixiao YANG , Xiaoyi CHEN , Yaodong ZHANG , Xiuan YANG . Early-onset epileptic encephalopathy type 27 caused by missense variation of GRIN2B gene: a case report[J]. Journal of Clinical Pediatrics, 2022 , 40(4) : 300 -305 . DOI: 10.12372/jcp.2022.21e0540
| [1] | Auvin S, Cilio MR, Vezzani A, et al. Current understanding and neurobiology of epileptic encephalopathies[J]. Neurobiol Dis, 2016, 92(Pt A):72-89. |
| [2] | Guo Z, Niu W, Bi Y, et a1. A study of single nucleotide polymorphisms of GRIN2B in schizophrenia from Chinese Han population[J]. Neurosci Lett, 2016, 630(6):132-135. |
| [3] | Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5):405-424. |
| [4] | Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009[J]. Epilepsia, 2010, 51(4):676-685. |
| [5] | Mercimek-Mahmutoglu S, Patel J, Cordeiro D, et al. Diagnostic yield of genetic testing in epileptic encephalopathy in childhood[J]. Epilepsia, 2015, 56(5):707-716. |
| [6] | McTague A, Howell KB, Cross JH, et al. The genetic landscape of the epileptic encephalopathies of infancy and childhood[J]. Lancet Neurol, 2016, 15(3):304-316. |
| [7] | Hu C, Chen W, Myers SJ, et al. Human GRIN2B variants in neurodevelopmental disorders[J]. J Pharmacol Sci, 2016, 132(2):115-121. |
| [8] | Platzer K, Yuan H, Schütz H, et al. GRIN2B ence-phalopathy: novel findings on phenotype, variant clustering, functional consequences and treatment aspects[J]. J Med Genet, 2017, 54(7):460-470. |
| [9] | Schidlitzki A, Twele F, Klee R, et al. A combination of NMDA and AMPA receptor antagonists retards granule cell dispersion and epileptogenesis in a model of acquired epilepsy[J]. Sci Rep, 2017, 7(1):12191-12210. |
| [10] | Addis L, Virdee JK, Vidler LR, et al. Epilepsy-associated GRIN2A mutations reduce NMDA receptor trafficking and agonist potency - molecular profiling and functional rescue[J]. Sci Rep, 2017, 7(1):66. |
| [11] | Li J, Zhang J, Tang W, et al. De novo GRIN variants in NMDA receptor M2 channel pore-forming loop are associated with neurological diseases[J]. Hum Mutat, 2019, 40(12):2393-2413. |
| [12] | Platzer K, Lemke JR. GRIN2B-Related Neuro-developmental Disorder[M]// Adam MP, Ardinger HH, Pagon RA, et al. GeneReviews®[Internet]. Seattle (WA): University of Washington, Seattle, 1993-2021. |
| [13] | Lemke JR, Hendrickx R, Geider K, et al. GRIN2B mutations in West syndrome and intellectual disability with focal epilepsy[J]. Ann Neurol, 2014, 75(1):147-154. |
| [14] | Mullier B, Wolff C, Sands ZA, et al. GRIN2B gain of function mutations are sensitive to radiprodil, a negative allosteric modulator of GluN2B-containing NMDA receptors[J]. Neuropharmacology, 2017, 123:322-331. |
/
| 〈 |
|
〉 |